This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
AUA 2018
AUA 2018
Prostate Cancer
Bladder Cancer
Renal Cancer
Testis & Penile Cancers
Lower Urinary Tract Conditions / Nocturia
GU Reconstruction
Infections & Inflammation
Laparoscopic / Robotic Surgery
Sexual Function
Stone Disease
Press Releases
AUA 2018 Renal Cancer
Viewing 21-40 of 90 articles
AUA 2018: Brain Metastasis from Renal Cell Carcinoma: An Institutional Study
AUA 2018: Use of Surveillance vs Active Treatment for Renal Masses ≤7 Cm: Results from the MUSIC KIDNEY Regional Collaborative
AUA 2018: Frozen Sections for Margins During Partial Nephrectomy Do Not Influence Recurrence Rates
AUA 2018: “Pin the Tumor on the Kidney”: An Evaluation of How Surgeons Translate CT and MRI data to 3D Models
AUA 2018: Is There a Role for Nephron Sparing Cytoreductive Partial Nephrectomy in Metastatic Renal Cell Carcinoma?
AUA 2018: Systematic Review and Meta-Analysis of Adjuvant Therapy After Nephrectomy for High-risk, Non-metastatic Renal Cell Carcinoma
AUA 2018: Rapid Patient Derived Xenografts that Consider Tumor Heterogeneity for Prediction of Cancer Immunotherapy Responses in Metastatic Renal Cell Carcinoma
AUA 2018: Does Tumor Size at the Time of Cytoreductive Nephrectomy Influence Survival?
AUA 2018: Renal Cell Carcinoma and Brain Metastasis: A SEER Analysis
AUA 2018: Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma: A Propensity-Score Based Analysis
AUA 2018: Postoperative Outcomes of Elderly Patients Undergoing Partial Nephrectomy: A Multicentric-Study of the French Research Network On Kidney Cancer UroCCR
AUA 2018: Tumor Enucleation: Functional Comparison with Standard Partial Nephrectomy
AUA 2018: Renal Function Variability Can Identify Subclinical Kidney Disease Before Nephrectomy
AUA 2018: Automated Digital Analysis of Renal Core Biopsy Specimens Using a Deep-Learning Artificial Intelligence Network
AUA 2018: Safety Lead-in of a Phase II Trial of Neo-Adjuvant SAbR for IVC tumor Thrombus in RCC
AUA 2018: Factors Driving Worse Survival Between Black and White Patients with Renal Cell Carcinoma
AUA 2018: Self-Reported Quality of Life for Predicting Mortality in Renal Cell Carcinoma
AUA 2018: Chest Follow-Up Schedule of Surgically Resected Renal Cell Carcinoma Should Be Differentiated According to Histological Subtype
AUA 2018: Validation of the Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer
AUA 2018: Pretreatment Diagnosis of the Small Renal Mass: Status of Renal Biopsy in the US
1
2
3
4
5
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free